Mechanism of action of TAK-475 and TAK-475 M-I. Simply explaining, TAK-475 and TAK-475 M-I accumulate MDIs, which are strongly decreased in MKD patients, and the increased MDIs stop inflammation via blocking the release of inflammatory cytokines as shown in Scheme 2